{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T21:12:45Z","timestamp":1778188365513,"version":"3.51.4"},"reference-count":47,"publisher":"Informa UK Limited","issue":"8","funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior \u2013 Brazil","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Council for Scientific and Technological Development \u2013 CNPq and FAPITEC-SE"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2020,8,2]]},"DOI":"10.1080\/13543776.2020.1789100","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T13:45:48Z","timestamp":1593524748000},"page":"633-641","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Pharmaceutical agents for treatment of leishmaniasis: a patent landscape"],"prefix":"10.1080","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4860-3455","authenticated-orcid":false,"given":"Yasmim Maria","family":"Barbosa Gomes de Carvalho","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Federal University of Sergipe, S\u00e3o Crist\u00f3v\u00e3o, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3781-8426","authenticated-orcid":false,"given":"Saravanan","family":"Shanmugam","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Federal University of Sergipe, S\u00e3o Crist\u00f3v\u00e3o, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayrton Santos","family":"Batista","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Federal University of Sergipe, S\u00e3o Crist\u00f3v\u00e3o, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4223-3470","authenticated-orcid":false,"given":"Mairim Russo","family":"Serafini","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Federal University of Sergipe, S\u00e3o Crist\u00f3v\u00e3o, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriano Antunes De Souza","family":"Ara\u00fajo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Federal University of Sergipe, S\u00e3o Crist\u00f3v\u00e3o, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5155-938X","authenticated-orcid":false,"given":"Lucindo Jos\u00e9","family":"Quintans J\u00fanior","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Federal University of Sergipe, S\u00e3o Crist\u00f3v\u00e3o, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,7,20]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.11120.1"},{"key":"cit0002","first-page":"1","volume":"2015","author":"Menezes J","year":"2015","journal-title":"Biomed Res Int"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-019-06443-2"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006052"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.10.022"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111660"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2019.1609940"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2014.993969"},{"key":"cit0009","unstructured":"Chow LM-C. Synthesis and use of amine-containing flavonoids as potent anti-leishmanial agentes. US 9562037. 2017."},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1039\/C9AN00948E"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.6383"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201800084"},{"key":"cit0013","unstructured":"Escario Garcia-Trevijano JA. Amines derived from 2-benzyl-5-nitroindazole with antiprotozoal properties against Trypanosoma, Leishmania and Trichomonas. WO 2019077174. 2019."},{"key":"cit0014","unstructured":"James MT, George TM. Pyrazolo[3,4-d]pyrimidin derivative and its use for the treatment of leishmaniasis. EP 3247713. 2017."},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23010134"},{"key":"cit0016","unstructured":"Gilbert IH, Thomas MG. Antileishmanial pyrazoloyirimidines. WO 2016116752. 2016."},{"key":"cit0017","unstructured":"Miles TJ, Thomas MG. Pyrazolo[3,4-d]pyrjmidin derivative and its use for the treatment of leishmaniasis. WO 2016116563. 2016."},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-1051-6"},{"key":"cit0019","unstructured":"Pollmeier M, Blair JJ. Method for treating and curing leishmaniosis using fexinindazole. WO 2014121064. 2014."},{"key":"cit0020","unstructured":"Kalpana B. Novel substituted benzocycloalkyl azole derivatives as antileishmanial agents. IN271474. 2016."},{"key":"cit0021","unstructured":"Camarasa R, Maria J. Triazole-phenyl-thiazole heterocycles as innovative inhibitors of tryphanothione redutase and their use leishmanicides. WO 2019122113. 2019."},{"key":"cit0022","unstructured":"Velez-Bernal ID. Cream formulation with amphotericin b and oil in water useful for topical application to mucous tissue and skin against diseases produced by leishmaniasis. US 9801895. 2017."},{"key":"cit0023","unstructured":"Gillet D. Adamantane or bicyclic monoterpenoid derivatives for use in the treatment of leishmaniasis. WO 2019086514. 2019."},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjtb.2015.05.018"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.2174\/1386207319666160506123921"},{"key":"cit0026","unstructured":"Maurya R, Chandrasekaran S. A novel synergistic composition for the treatment of visceral leishmaniasis. WO 2017046778. 2017."},{"key":"cit0027","unstructured":"Baker BJ, Witowski CG, Maschek JA, et al. Diterpenoide membranolide compounds having anti-leishmania acitivity and uses thereof. US 20160030388. 2016."},{"key":"cit0028","unstructured":"Auclair C, Fellous E, Le Pape P, et al. Topical compositions for the treatment of cutaneous leishmaniasis. WO 2019043212. 2019."},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-018-5975-7"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1007\/s11259-018-9714-4"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.46582\/jsrm.0101005"},{"key":"cit0032","first-page":"384","volume":"3","author":"Cenini P","year":"1998","journal-title":"J Protozool"},{"key":"cit0033","unstructured":"Barth S, Thepen T, Barral-Netto M, et al. An Immunotoxin for use in the treatment of leishmaniasis. WO 2016116550. 2016."},{"key":"cit0034","unstructured":"Qvit N, Mochly-Rosen D, Schechtman D, et al. Compositions and methods for specific inhibition of Leishmania receptor for activated c-kinase (lack). WO 2014036198. 2014."},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1007\/s004360050272"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.06.018"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2017.02.019"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.10701.1"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S203351"},{"key":"cit0040","unstructured":"Britti D, Cosco D, Fresta M, et al. Nanoparticulate systems for vehiculating drugs for the treatment of Leishmania infection-related pathologies. WO 2015177820. 2015."},{"key":"cit0041","unstructured":"Frezard FJG, Azevedo EG, Bibeiro RR, et al. Pharmaceutical composition containing conventional liposomes and prolonged-circulation liposomes for the treatment of visceral leishmaniasis. US 2015\/0306035. 2015."},{"key":"cit0042","unstructured":"World Health Organization (WHO). Leishmaniasis. [cited 2020 Feb 7]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis"},{"key":"cit0043","unstructured":"National Library of Medicine. Medications for leishmaniasis. [cited 2020 Feb 7]. Available from: https:\/\/www.drugs.com\/condition\/leishmaniasis.html"},{"key":"cit0044","unstructured":"Drugs for Neglected Diseases initiative (DNDi). Towards a new generation of treatments for leishmaniasis. [cited 2020 Feb 7]. Available from: https:\/\/www.dndi.org\/wp-content\/uploads\/2018\/12\/DNDi_Leishmaniasis_2018.pdf"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007173"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1016\/S1995-7645(12)60084-4"},{"key":"cit0047","first-page":"25","volume":"12","author":"Ghorbani M","year":"2018","journal-title":"Dovepress"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2020.1789100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T14:51:00Z","timestamp":1620485460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2020.1789100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,20]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8,2]]}},"alternative-id":["10.1080\/13543776.2020.1789100"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2020.1789100","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-08-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}